FDA Inspection 1131467 — David J. Smith Jr, MD
The FDA completed an inspection of David J. Smith Jr, MD on October 13, 2020 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Tampa, FL (United States)
Additional Details
Clinical Investigator (CI)